• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管迷走性晕厥的循证治疗

Evidence-based treatment for vasovagal syncope.

作者信息

Kuriachan Vikas, Sheldon Robert S, Platonov Michael

机构信息

Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.

出版信息

Heart Rhythm. 2008 Nov;5(11):1609-14. doi: 10.1016/j.hrthm.2008.08.023. Epub 2008 Aug 28.

DOI:10.1016/j.hrthm.2008.08.023
PMID:18984541
Abstract

Only a minority of patients with vasovagal syncope require treatment, and most can be managed conservatively. Patients should be encouraged to liberalize their fluid and salt intake, unless they have contraindications such as hypertension. All patients should be taught physical counterpressure maneuvers. Midodrine is the first-line therapy for patients having frequent presyncope or syncope or for those with brief or no prodromes. The routine use of beta-blockers, serotonin-specific reuptake inhibitors, fludrocortisone, and pacemakers is discouraged. Whether loop recorders can be used to target treatment is under investigation, as is fludrocortisone.

摘要

只有少数血管迷走性晕厥患者需要治疗,大多数患者可采用保守治疗。应鼓励患者增加液体和盐分摄入,除非他们有高血压等禁忌证。应向所有患者传授物理对抗压力动作。米多君是有频繁晕厥前症状或晕厥的患者或前驱症状短暂或无前驱症状患者的一线治疗药物。不建议常规使用β受体阻滞剂、5-羟色胺特异性再摄取抑制剂、氟氢可的松和起搏器。目前正在研究是否可使用环路记录器来指导治疗,氟氢可的松的情况也在研究中。

相似文献

1
Evidence-based treatment for vasovagal syncope.血管迷走性晕厥的循证治疗
Heart Rhythm. 2008 Nov;5(11):1609-14. doi: 10.1016/j.hrthm.2008.08.023. Epub 2008 Aug 28.
2
Clinical practice. Neurocardiogenic syncope.临床实践。神经心源性晕厥。
N Engl J Med. 2005 Mar 10;352(10):1004-10. doi: 10.1056/NEJMcp042601.
3
What can I do when first-line measures are not enough for vasovagal syncope?当一线治疗措施对血管迷走性晕厥无效时我该怎么办?
Cleve Clin J Med. 2018 Dec;85(12):920-922. doi: 10.3949/ccjm.85a.17112.
4
Strategy for the management of vasovagal syncope.血管迷走性晕厥的管理策略。
Drugs Aging. 2002;19(3):179-202. doi: 10.2165/00002512-200219030-00003.
5
Pharmacologic approaches to therapy for vasovagal syncope.血管迷走性晕厥的药物治疗方法。
Am J Cardiol. 1999 Oct 21;84(8A):20Q-25Q. doi: 10.1016/s0002-9149(99)00626-8.
6
Management of vasovagal syncope.血管迷走性晕厥的管理。
J Cardiovasc Electrophysiol. 1999 Jun;10(6):874-86. doi: 10.1111/j.1540-8167.1999.tb00270.x.
7
Current approach to the treatment of vasovagal syncope in adults.成人血管迷走性晕厥的当前治疗方法。
Intern Emerg Med. 2023 Jan;18(1):23-30. doi: 10.1007/s11739-022-03102-w. Epub 2022 Sep 18.
8
Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.用于血管迷走性、颈动脉窦和情境性晕厥的药物及起搏器。
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004194. doi: 10.1002/14651858.CD004194.pub3.
9
Neurocardiogenic syncope in children : current concepts in diagnosis and management.儿童神经心源性晕厥:诊断与管理的当前概念
Paediatr Drugs. 2003;5(5):327-34. doi: 10.2165/00128072-200305050-00005.
10
Management strategies for recurrent vasovagal syncope.复发性血管迷走性晕厥的管理策略。
Intern Med J. 2010 Aug;40(8):554-60. doi: 10.1111/j.1445-5994.2010.02295.x.

引用本文的文献

1
Serotonin and vasovagal syncope.血清素与血管迷走性晕厥。
Clin Auton Res. 2024 Aug;34(4):385-394. doi: 10.1007/s10286-024-01052-1. Epub 2024 Jul 9.
2
Twenty-five years of research on syncope.晕厥研究 25 年
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad163.
3
Reducing Unnecessary Diagnostic Testing in Pediatric Syncope: A Quality Improvement Initiative.减少儿科晕厥中不必要的诊断性检查:一项质量改进计划。
Pediatr Cardiol. 2021 Apr;42(4):942-950. doi: 10.1007/s00246-021-02567-4. Epub 2021 Feb 13.
4
Fludrocortisone in Pediatric Vasovagal Syncope: A Retrospective, Single-Center Observational Study.氟氢可的松治疗小儿血管迷走性晕厥:一项回顾性单中心观察性研究。
J Clin Neurol. 2021 Jan;17(1):46-51. doi: 10.3988/jcn.2021.17.1.46.
5
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope.植入式循环记录仪与不明原因复发性晕厥的传统诊断检查方法对比
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD011637. doi: 10.1002/14651858.CD011637.pub2.
6
Comparative Clinical Pharmacokinetics of Midodrine and Its Active Metabolite Desglymidodrine in Cirrhotic Patients with Tense Ascites Versus Healthy Volunteers.米多君及其活性代谢物去甘米多君在肝硬化腹水患者与健康志愿者中的比较临床药代动力学
Clin Drug Investig. 2016 Feb;36(2):147-55. doi: 10.1007/s40261-015-0359-6.
7
2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.2015年心律协会关于体位性心动过速综合征、不适当窦性心动过速和血管迷走性晕厥诊断与治疗的专家共识声明
Heart Rhythm. 2015 Jun;12(6):e41-63. doi: 10.1016/j.hrthm.2015.03.029. Epub 2015 May 14.
8
Cardiac syncope due to pain: report of a case responsive to duloxetine treatment.疼痛所致的心源性晕厥:1例对度洛西汀治疗有反应的病例报告。
Herz. 2013 Sep;38(6):683-4. doi: 10.1007/s00059-012-3734-6. Epub 2013 Apr 17.
9
Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.用于血管迷走性、颈动脉窦和情境性晕厥的药物及起搏器。
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004194. doi: 10.1002/14651858.CD004194.pub3.
10
Treatment of vasovagal syncope: an update.血管迷走性晕厥的治疗:最新进展
Curr Treat Options Cardiovasc Med. 2010 Oct;12(5):472-88. doi: 10.1007/s11936-010-0087-4.